Skin cancer patients on NHS will get 'life-changing' new drug cemiplimab
Cemiplimab will be available to hundreds of patients with advanced squamous cell carcinoma who haven't responded to surgery and radiotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2022 Category: Consumer Health News Source Type: news
FDA approves Opdivo in combination with chemotherapy and Opdivo in combination with Yervoy for first-line esophageal squamous cell carcinoma indications
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 31, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news
U.S. Food and Drug Administration Approves Two Opdivo (nivolumab)-Based Regimens as First-Line Treatments for Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Opdivo in combination with chemotherapy and Opdivo plus Yervoy® (ipilimumab) approved based on a Phase 3 trial showing improved overall survival versus chemotherapy alone1,2
Opdivo-based treatments are now approved for five indications in... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 30, 2022 Category: Drugs & Pharmacology Source Type: news
Mayo Clinic Minute: Treating skin cancer with Mohs surgery
May is Skin Cancer Awareness Month and a time to check your body for signs of this common and preventable disease. Nearly 5 million people in the U.S. will be diagnosed with a form of skin cancer this year, according to the American Cancer Society. Dr. Naiara Sbroggio Barbosa (Nie-e-ARE-ah Bar-BOH-sah), a Mayo Clinic dermatologist, , explains how Mohs surgery can be used to treat basal cell carcinoma, squamous cell carcinoma and some types of melanoma.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 27, 2022 Category: Databases & Libraries Source Type: news
Biomarker Panel to Detect Esophageal Squamous Cell Cancer (ESCC) Biomarker Panel to Detect Esophageal Squamous Cell Cancer (ESCC)
A biomarker panel used on tissue samples obtained via a swallowable capsule can detect esophageal squamous cell cancer (ESCC) and may be particularly useful where endoscopy is not widely available.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 25, 2022 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT
MONDAY, May 23, 2022 -- For patients receiving concurrent chemoradiotherapy for squamous cell carcinoma of the head and neck, higher doses of gabapentin are well tolerated and associated with delayed time to first opioid use for additional pain... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2022 Category: Pharmaceuticals Source Type: news
Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer Liquid Biopsy Predicts Resistance to Neoadjuvant Therapy in Esophageal Cancer
Researchers have developed and validated a liquid biopsy assay that can predict response to neoadjuvant therapy in patients with esophageal squamous-cell carcinoma, which may lead to more personalized treatment decisions.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 18, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
Non-endoscopic Method to Detect Esophageal Cancer Promising Non-endoscopic Method to Detect Esophageal Cancer Promising
Esophageal squamous-cell carcinoma can be detected by analyzing a panel of methylated DNA biomarkers in cytologic samples obtained via a swallowable sponge-capsule device, researchers have found.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 5, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
What is in the Differential Diagnosis for Red, Orange or Yellow Skin Conditions?
Discussion
This is the first in a short case series of differential diagnoses of colored skin conditions.
A differential diagnosis by distribution and common pattern can be found here.
For green, blue and violet conditions, a review can be found here.
For black and white conditions, a review can be found here.
For brown and grey conditions, a review can be found here.
Note that any color can be a normal variant for an individual or is physiologic for a given state.
The skin is the largest organ of the body. It can be easily examined but for many clinicians continues to be difficult to describe what they are seeing. Analo...
Source: PediatricEducation.org - April 25, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Dracen Pharmaceuticals announces two presentations at the American...
Data support that sirpiglenastat (DRP-104) has therapeutic potential in targeting KEAP1-mutant lung cancer as well as squamous cell carcinoma of the head and neck(PRWeb April 08, 2022)Read the full story at https://www.prweb.com/releases/2022/4/prweb18601225.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2022 Category: Pharmaceuticals Source Type: news
Mixed Message for Ultrasound in High-Risk Cutaneous Head and Neck Cancer
(MedPage Today) -- Ultrasound outperformed baseline clinical assessment for detection of lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma (SCC) of the head and neck, a retrospective Dutch study showed.
Imaging... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 18, 2022 Category: Dermatology Source Type: news
Management of Cutaneous SCC of the Scalp With Brain Exposure Management of Cutaneous SCC of the Scalp With Brain Exposure
This case of advanced squamous cell carcinoma of the scalp with exposure of the brain was managed with a palliative approach.Wounds (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 16, 2022 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news
Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence? Can Liquid Biopsy Predict Oropharyngeal Cancer Recurrence?
Performing a routine liquid biopsy test for HPV DNA may allow recurrence of oropharyngeal squamous cell carcinoma to be identified before clinical signs develop, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Mayo Clinic Q & amp;A podcast: Recognizing skin cancer and reducing your risk
Skin cancer — the abnormal growth of skin cells — most often develops on skin exposed to the sun, but it also can occur on areas of skin not ordinarily exposed to sunlight. Skin cancer is the most common form of cancer in the U.S. "And the incidence of skin cancer is rising," says Dr. Dawn Davis, a Mayo Cli nic dermatologist. The three major types of skin cancer are basal cell carcinoma, squamous cell carcinoma… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 24, 2022 Category: Databases & Libraries Source Type: news
Nivolumab Combo Treats Advanced Esophageal Squamous - Cell Carcinoma
Overall survival longer in patients receiving first - line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 3, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Journal, Source Type: news
